AMMOIDIN 0.75% Ointment 30g

Frequently asked questions

• Onset of action

  The effect of this medicine can be observed within 1 to 3 hours of administration of the dose.

• Duration of Effect

  The amount of time for which this medicine remains active is subject to vary based on the dosage form and individual constitution.

• Safe with Alchohol?

  Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

• Is it habit forming?

  No habit-forming tendencies were reported.

• Usage in pregnancy?

  This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using/receiving this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

• Usage while breast-feeding?

  Oral and Extracorporeal dosage forms: This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking/receiving this medicine. Your doctor may advise you to stop breastfeeding for a specific period of time during treatment with this medicine. Topical forms: This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine. If the medicine is used, care should be taken such that the infant does not come into contact with the medicine.

• Allergy

  This medicine is not recommended for use in patients with a known allergy to AMMOIDIN 0.75% Ointment 30g , any psoralen compounds, or any other inactive ingredients present along with it.

• Aphakia

  This medicine is not recommended for use in patients suffering from aphakia due to the increased risk of worsening of the patient's condition.

• Melanoma

  This medicine is not recommended for use in patients with a history of melanoma due to the increased risk of worsening of the patient's condition.

• Squamous Cell Carcinoma

  This medicine is not recommended for use in patients with invasive squamous cell carcinomas due to the increased risk of worsening of the patient's condition.

• Pregnancy

  This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using/receiving this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

• Breast-feeding

  Oral and Extracorporeal dosage forms: This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking/receiving this medicine. Your doctor may advise you to stop breastfeeding for a specific period of time during treatment with this medicine. Topical forms: This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine. If the medicine is used, care should be taken such that the infant does not come into contact with the medicine.

• Driving and operating machinery

  This medicine may affect the ability to drive and operate machines. Hence, the patient should not drive or operate machines immediately after the treatment.

• Aging of skin and skin burning

  After receiving treatment with this medicine and ultra-violet light, further exposure to sunlight and/or ultraviolet radiation may result in premature aging of the skin as well as serious burns. Patients should take all precautionary measures, as advised by the doctor, including covering the skin, using a sun blocking agent, wearing sunglasses, etc. in case they need to go outdoors.

• Carcinogenicity

  The use of this medicine and ultraviolet radiation therapy significantly increases the risk of cancer. This risk is especially higher in patients with a previous history of cancer or radiation therapy. All the risks and benefits should be discussed with the doctor before using/receiving this medicine.

• Use in children

  This medicine is not recommended for use in patients less than 12 years of age. However, even for patients under the age of 18 years, it should be used only if the benefits significantly outweigh the risks and only under the supervision of a healthcare professional.

Use/Take this medicine exactly as prescribed by your doctor. Follow all the instructions given on the label/package insert. The oral form of this medicine should be taken with food or milk. Do not sunbathe for 24 hours before using/receiving AMMOIDIN 0.75% Ointment 30g and having the UVA light treatment. For 24 hours following the treatment, avoid exposure to sunlight or artificial UV rays (sunlamps or tanning beds). You are advised to take all precautionary measures such as wearing protective clothing, wearing a sunblock, wearing sunglasses, etc. if you need to go outdoors within 24 hours of therapy.

• To be taken with food
• To be taken as instructed by doctor
• May cause sleepiness

• webmd.com - Methoxsalen [Internet]. Available from: https://www.webmd.com/drugs/2/drug-6957-1257/methoxsalen-oral/methoxsalen-rapid-oral/details [cited 8/9/2020].
• wikipedia.org - Methoxsalen [Internet]. Available from: https://en.wikipedia.org/wiki/Methoxsalen [cited 8/9/2020]. 2020